Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voclosporin extension in plaque psoriasis
NCT00258713Phase 3Completed
- Sponsor
- Aurinia
- Start
- Sep 2005
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of voclosporin in plaque psoriasis (3 arms), sponsored by Aurinia. Primary endpoint: Long-term safety and tolerability of voclosporin at 60 weeks. Started Sep 2005; status: completed.
02
Drugs
voclosporin
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00258713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00258713.